Perlecan heparan sulfate deficiency impairs pulmonary vascular development and attenuates hypoxic pulmonary hypertension.
Chang YT, Tseng CN, Tannenberg P, Eriksson L, Yuan K, de Jesus Perez VA, Lundberg J, Lengquist M, Botusan IR, Catrina SB, Tran PK, Hedin U, Tran-Lundmark K.
Chang YT, et al. Among authors: tseng cn.
Cardiovasc Res. 2015 Jul 1;107(1):20-31. doi: 10.1093/cvr/cvv143. Epub 2015 May 6.
Cardiovasc Res. 2015.
PMID: 25952902